Company Filing History:
Years Active: 1981
Title: Sirpa A Tuomi: Innovator in Antihypertensive Drug Development
Introduction
Sirpa A Tuomi is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive medications. His innovative work has led to the creation of a method that enhances the production of a specific drug used to treat high blood pressure.
Latest Patents
Sirpa A Tuomi holds 1 patent for a method of producing 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl] quinazoline hydrochloride, commonly known as prazosine hydrochloride. This improved method involves the reaction of methyl-N-(3,4-dimethoxy-6-cyano-phenyl)-[4-(2-furoyl)-1-piperazinyl] thioformamidate with a large excess of ammonium chloride. This advancement is crucial for enhancing the efficiency of drug production.
Career Highlights
Sirpa A Tuomi is associated with Orion-yhtyma Oy, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative drug development, contributing to the company's reputation for excellence in healthcare solutions.
Collaborations
Throughout his career, Sirpa has collaborated with esteemed colleagues, including Erkki J Honkanen and Aino K Pippuri. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Sirpa A Tuomi's contributions to antihypertensive drug development exemplify the impact of innovation in the pharmaceutical industry. His patented method for producing prazosine hydrochloride showcases his commitment to improving healthcare solutions.